CIK: 0001823138 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $409,536 (97.5% shares, 2.5% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INDIVIOR PLC | 13,810,893 | $210,892 | 51.5% | $23.71 | — | ORD | G4766E116 |
| ROIV | ROIVANT SCIENCES LTD | 8,508,223 | $95,547 | 23.3% | $5.52 | +76.6% | SHS | G76279101 |
| ESPR | ESPERION THERAPEUTICS INC NE | 7,686,120 | $22,981 | 5.6% | $1.43 | -9.1% | COM | 29664W105 |
| ABUS | ARBUTUS BIOPHARMA CORP | 9,041,927 | $22,605 | 5.5% | $2.63 | -25.4% | COM | 03879J100 |
| MMM | 3M CO | 144,789 | $15,828 | 3.9% | $79.15 | -4.6% | COM | 88579Y101 |
| — | ESPERION THERAPEUTICS INC NE | 17,275,000 | $10,041 | 2.5% | $0.54 | — | NOTE 4.000%11/1 | 29664WAB1 |
| META | META PLATFORMS INC | 26,175 | $9,265 | 2.3% | $218.77 | +47.8% | CL A | 30303M102 |
| IMVT | IMMUNOVANT INC | 198,752 | $8,373 | 2.0% | $22.60 | +62.8% | COM | 45258J102 |
| OMEX | ODYSSEY MARINE EXPL INC | 1,371,874 | $6,379 | 1.6% | $5.35 | -31.9% | COM NEW | 676118201 |
| IMVT | IMMUNOVANT INC | 86,600 | $3,648 | 0.9% | $22.60 | +62.8% | Call | 45258J102 |
| SONO | SONOS INC | 179,732 | $3,081 | 0.8% | $16.16 | -16.5% | COM | 83570H108 |
| HTZ | HERTZ GLOBAL HLDGS INC | 77,188 | $802 | 0.2% | $25.48 | -62.1% | COM NEW | 42806J700 |
| HTZWW | HERTZ GLOBAL HLDGS INC | 16,841 | $92 | 0.0% | $10.08 | — | *W EXP 06/30/205 | 42806J148 |